SpeeDx
Business Services · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1601 Trinity St Bldg B, Austin, Texas, 7...Phone Number
+44 3304450036Website
www.plexpcr.comRevenue
$17.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About SpeeDx
SpeeDx specializes in innovative molecular diagnostics, focusing on the detection of viral and bacterial infections as well as antibiotic resistance markers. Their product offerings include multiplex assays for sexually transmitted infections and respiratory infections, designed for research use only. Founded in 2009, the company operates globally with offices in Austin, London, and Sydney, catering to laboratories and research institutions. SpeeDx aims to enhance laboratory workflows and improve productivity through advanced qPCR technology and automation solutions.Explore more
SpeeDx Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SpeeDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if SpeeDx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
SpeeDx, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at SpeeDx
Check out if SpeeDx is spiking on competitors!
Funding: Get notified immidiatlly once SpeeDx has new funding data
Earning: See what the market has to say on SpeeDx recently announced quarterly report
Product Launch: Get notified when SpeeDx launches new products
Click to see if SpeeDx had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at SpeeDx
Find 2 more new buyers
Compare Similar Companies to SpeeDx
Compare insights from companies similar to SpeeDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SpeeDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SpeeDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SpeeDx.
SpeeDx financials insights
Gather financial insights about SpeeDx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Private Equity
$10M
SpeeDx Tech Stack
A closer look at the technologies used by SpeeDx
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology, HR Operations, Operations
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Event
Events, eCommerce, Logistics / Supply Chain, Operations, Warehouse Operations
Event
SpeeDx News & Media
SpeeDxがSARS-CoV-2 Genotyping試薬ポートフォリオの適用範囲をさらに拡充
シドニー--(BUSINESS WIRE)--（ビジネスワイヤ） -- 革新的な分子診断ソリューションの開発を手掛けるSpeeDx Pty. Ltd.は、COVID-19変異株解析用の研究試薬の製品ラインアップをさらに拡大し、注目すべき変異株（VOI）であるSARS-CoV-2ラムダ株と関連した重要特性の変異にも対応しました。PlexPrime® SARS-CoV-2 Genotyping*の製品ラインアップは、当社独自のユニバーサル基質手法と、特許取得済みのマルチプレックス技術を利用し、7月に上市してから急速に拡大しました。これら一連の製品は、単独または他の製品との組み合わせで、SARS-CoV-2の重要なVOIないし懸念される変異株（VOC）に対するラボ研究やモニタリング活動を支えることに使用できます。 SpeeDxのクリニカルアフェアーズ担当シニアバイスプレジデントであるチャールズ・カートライト博士は、次のように述べています。「PCR法による陽性検体の迅速なスクリーニングにより、変異株が伝播した際に各ラボは容易にモニタリングができます。当社の一連のジェノタイピング用試薬が対象とSpeeDx enrichit son portefeuille de réactifs de génotypage du SRAS-CoV-2
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd., un développeur de solutions innovantes de diagnostic moléculaire, continue d’élargir sa gamme de réactifs de recherche pour l’analyse des variants de la Covid-19. Cette ligne de produits inclut désormais une caractéristique essentielle de mutation liée au variant d’intérêt Lambda du SRAS-CoV-2. La gamme de produits de génotypage PlexPrime® du SRAS-CoV2* s’est rapidement étoffée depuis son lancement en juillet, grâce à l’utilisation de l’approche uniqueRiassunto: SpeeDx realizza un'ulteriore copertura nel portafoglio di reagenti per la genotipizzazione SARS-CoV-2
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd., uno sviluppatore di soluzioni diagnostiche molecolari innovative, ha ulteriormente ampliato la gamma di reagenti di ricerca for l'analisi di varianti del COVID-19 per includere un'importante mutazione delle caratteristiche connessa alla variante di interesse (VOI) Lambda del SARS-CoV-2. La linea di prodotti PlexPrime® SARS-CoV-2 Genotyping* si è ampliata rapidamente dal lancio del luglio scorso, utilizzando l'esclusivo approccio al substrato universaleSpeeDx constrói mais cobertura no portfólio de reagentes de genotipagem do SARS-CoV-2
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd., desenvolvedora de soluções inovadoras de diagnóstico molecular, expande ainda mais sua linha de produtos de reagentes de pesquisa para análise de variante da COVID-19 para incluir uma mutação chave característica ligada à variante de preocupação do SARS-CoV-2 Lambda (VOI). A linha de produtos PlexPrime® SARS-CoV-2 Genotyping* se expandiu rapidamente desde seu lançamento em julho, utilizando a abordagem exclusiva de substrato universal da empresa e a te
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SpeeDx
Sign Up For FreeTo access detailed company insights
SpeeDx specializes in innovative molecular diagnostics, focusing on the detection of viral and bacterial infections as well as antibiotic resistance markers. Their product offerings include multiplex assays for sexually transmitted infections and respiratory infections, designed for research use only. Founded in 2009, the company operates globally... Read More
